tetravalent bispecific CCR5 antibodies (Roche)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Nametetravalent bispecific CCR5 antibodies (Roche)

Drug Alias NameCCR5-2320

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionC-C chemokine receptor type 5 modulators

TargetsC-C chemokine receptor type 5

Therapy Area/IndicationsHIV Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryGermany

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesRoche Diagnostics Gmbh

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesRoche Diagnostics Gmbh

Active IndicationsN/A

Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A